Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
COVID-19 and Cardiovascular diseases. Scoping review study
Insights
Patients with cardiovascular disease face a higher risk of severe COVID-19 and death. New heart damage during COVID-19 infection is linked to poor outcomes, necessitating further research.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 frequently co-occurs with pre-existing cardiovascular diseases.
- Acute cardiac damage is a common complication during COVID-19 infection.
Purpose of the Study:
- To assess the risk of COVID-19 in individuals with pre-existing cardiovascular conditions.
- To identify and describe new cardiovascular manifestations arising from COVID-19.
Main Methods:
- A comprehensive scoping review of published research was conducted.
- PubMed was utilized as the primary database for literature retrieval.
Main Results:
- Cardiovascular disease patients exhibit increased COVID-19 risk, particularly severe forms, with a 5-10 times higher mortality rate.
- Acute myocardial damage, indicated by elevated cardiac troponins, affected 7-17% of hospitalized COVID-19 patients.
- New cardiac lesions in COVID-19 patients consistently correlated with a worse prognosis.
Conclusions:
- The COVID-19 pandemic presents a significant cardiovascular challenge.
- The prognostic implications of cardiac damage underscore the need for high-evidence research.
Background:
Many patients with COVID-19 have pre-existing cardiovascular (CV) co-morbidities or develop acute heart damage during the course of the disease.
Objectives:
To study the risk of COVID-19 infection in the presence of preexisting CV diseases and to describe new CV manifestations during COVID-19.
Methods:
A "scoping review" was carried out via PubMed, to synthesize the results of research currently published on this subject.
Results:
Patients with cardiovascular disease were at greater risk of developing COVID-19, especially in its severe form. These patients were five to ten times more at risk of death. Cardiac manifestations, de novo, were dominated by acute myocardial damage, defined by a significant elevation of cardiac troponins. These occurred in 7 to 17% of hospitalized patients. The presence of a new heart lesion in patients with COVID-19 was consistently associated with a poor prognosis.
Conclusion:
Given the enormous cardiovascular challenge posed by the COVID-19 pandemic and the prognostic impact of heart damage, additional research at a high level of evidence will be necessary.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction

